Valcare, Inc.
USPTO PatentsView assignee record - 30 granted patents across 5 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Valcare ranks #10,499 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 5 technology areas.
- #10,499
- of 49,997 US assignees by volume
- Top 37%
- by Innovation Score (39.9/100)
- 13.8
- avg claims per patent
- +300%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R10499 · Foreign Corporation #10,499 · 30 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 30 grants
- UPPER-Q #10,499/49,997
- PHOTO-FINISH United Laboratories…
- CPC-NARROW A61F · 5 areas
- INNOV-THIN 39.9/100
- CLAIMS-RICH 13.8 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +300% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: United Laboratories International, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Valcare’s 39.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Valcare
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Apaq Technology · near
Apaq Technology · near
40 score
- Kama-Tech (HK) · near
Kama-Tech (HK) · near
40 score
- Stella Chemifa · near
Stella Chemifa · near
40 score
- Stitch Fix · near
Stitch Fix · near
40 score
- Valcare · this assignee
Valcare · this assignee
40 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Valcare's Innovation Score is 39.9/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Valcare?
Each dot is one of Valcare’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Valcare’s own 13.8 claims/patent is at or below the 16.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Valcare's grants concentrate
Valcare, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 80% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2023 (10 grants) versus a trough of 1 in 2015. By volume, Valcare sits between Universitaet Zuerich and VirnetX, Inc..
Valcare's three-year grant acceleration
Valcare, Inc. shows 16 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Valcare's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Universitaet Zuer…
Universitaet Zuerich
30 patents
- University Hospit…
University Hospitals Cleveland Medical Center
30 patents
- United Laboratori…
United Laboratories International, LLC
30 patents
- University of Ida…
University of Idaho
30 patents
- Vemag Maschinenbau
Vemag Maschinenbau GmbH
30 patents
- VON Ardenne Asset…
VON Ardenne Asset GmbH & Co KG
30 patents
- Verathon
Verathon Inc.
30 patents
- Virnetx
VirnetX, Inc.
30 patents
- Valcare ◀
Valcare, Inc.
30 patents
What this shows Valcare holds 30 patents at rank #10,499, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Valcare
By rank, the assignees closest to #10,499 in granted patent volume.
- Universitaet Zuerich #10,495 · 30 patents
- University Hospitals Cleveland Medical Center #10,496 · 30 patents
- United Laboratories International, LLC #10,497 · 30 patents
- University of Idaho #10,498 · 30 patents
- Vemag Maschinenbau GmbH #10,500 · 30 patents
- VON Ardenne Asset GmbH & Co KG #10,501 · 30 patents
- Verathon Inc. #10,502 · 30 patents
- VirnetX, Inc. #10,503 · 30 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Valcare's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Valcare, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Valcare ranks #275 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (40 here).
Valcare's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 37% higher than 63% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 3.3% |
| 2016 | 2 | 6.7% |
| 2017 | 2 | 6.7% |
| 2019 | 1 | 3.3% |
| 2020 | 5 | 16.7% |
| 2021 | 3 | 10.0% |
| 2022 | 5 | 16.7% |
| 2023 | 10 | 33.3% |
| 2024 | 1 | 3.3% |
Which technologies does Valcare, Inc. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Valcare, Inc.'s patent record in context - here's where to go next.
- Valcare, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 80% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #10,499 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Valcare, Inc. against Universitaet Zuerich, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 39.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.